Written and maintained by CASRAI Editorial Board
Last updated
Short answer
Geroscience is the interdisciplinary field that studies the biological mechanisms of aging in order to understand how aging enables chronic disease. Its central bet is that aging is the greatest risk factor for most chronic diseases, so intervening in shared aging biology could delay several diseases together.
Definition and scope
This page defines the field, sets out the geroscience hypothesis, lists the seven research pillars proposed by a 2014 expert group, and shows what changes in study design when a project is framed this way. It is general information for researchers and lab staff, not medical advice.
The American Federation for Aging Research describes geroscience as “the interdisciplinary field that studies the biological mechanisms of aging,” linking those mechanisms to chronic and age-related disease (AFAR, read 2026-11-08). A special-issue introduction in Aging Medicine frames the approach as therapeutically addressing aging and its mechanisms directly, to prevent or lessen several chronic diseases together, and presents that as potentially more efficient than tackling one disease at a time (Leng, Liu and Kennedy, 2019).
Geroscience is a research orientation, not a clinical specialty. It draws on molecular biology, model-organism genetics, immunology, metabolism and epidemiology. Clinical care of older adults belongs to geriatrics, and the study of aging across social and biological dimensions to gerontology; see geriatrics vs gerontology for that distinction. Journal-level coverage of the field is described in the npj Aging guide.
How it works: the geroscience hypothesis in practice
Kennedy and colleagues (Cell, 2014) state that “aging is the greatest risk factor for a majority of chronic diseases driving both morbidity and mortality,” and that interventions which extend lifespan in model organisms “often delay or prevent many chronic diseases.” From this they argue that geroscience research aimed at extending human healthspan should be expanded, and they call for a broad set of interventional strategies for human testing. The hypothesis therefore has three linked parts:
- Aging is the dominant risk factor for many chronic diseases.
- Those diseases share upstream biological processes of aging.
- Changing those processes in model organisms has delayed or prevented several diseases, which motivates testing in humans.
AFAR adds that many biological processes of aging are “flexible and responsive to intervention.” Each part is a hypothesis under test, and the 2014 paper is explicit that human testing is still to be designed.
Types or related concepts: the seven pillars of aging
The 2014 paper grew out of a summit of researchers who identified seven themes. The authors stress that “the themes were not seven independent factors driving aging, rather highly intertwined processes.” The table lists the pillars with the research goals the paper’s Table 1 assigns to each (paraphrased).
| Pillar | Research goal stated in the paper |
|---|---|
| Adaptation to Stress | Link psychological and molecular stress; separate hormetic responses from toxic stress. |
| Epigenetics | Develop biomarkers of chronological versus biological aging; link environmental inputs to epigenetic change. |
| Inflammation | Distinguish adaptive from maladaptive inflammation and identify age-related inflammatory sources. |
| Macromolecular Damage | Build a systems-level understanding of damage types and their role in chronic disease. |
| Metabolism | Clarify metabolic signaling and circadian contributions, and how metabolic dysfunction drives tissue decline. |
| Proteostasis | Identify proteostatic pathways that fail in disease and how they interact. |
| Stem Cells and Regeneration | Determine whether declining adult stem cell function drives aging and chronic disease. |
Where it matters for labs
The following is editorial interpretation built on the sources above, not a rule from any of them. A single-disease study usually defines its endpoint as the disease itself. A geroscience-framed study asks whether an intervention changes a shared mechanism and whether that change shows up across several outcomes. The comparison below summarises how the framing differs.
| Question | Single-disease framing | Geroscience framing |
|---|---|---|
| Target | One disease and its pathology | Aging processes shared across diseases (AFAR; Kennedy et al.) |
| Rationale | Disease-specific mechanism | Aging is the greatest risk factor for most chronic diseases (Kennedy et al.) |
| Evidence base cited | Disease models | Lifespan-extending interventions in model organisms that also delay chronic disease (Kennedy et al.) |
| Design consequence (interpretation) | One primary disease endpoint | Mechanism-level measures, such as the pillar-linked biomarkers in the table above, alongside several disease outcomes |
Because the pillars are intertwined, a protocol that measures only one pillar may miss interactions the authors consider critical. Age-dependent outcomes also need time: see longitudinal study design for the trade-offs, surrogate endpoint validation for what it takes before a biomarker can stand in for a clinical outcome, and translational research for the path from model organism to human testing.
Common misunderstandings
- “Geroscience says aging is a disease.” The sources define it as the study of aging mechanisms and their link to chronic disease; they do not make that claim.
- “It is about living longer.” The 2014 paper and AFAR frame the goal as healthspan, the years lived in good health, not lifespan alone.
- “The mechanisms are settled.” The paper calls for human testing; much of the supporting evidence it cites comes from model organisms.
- “Seven pillars means seven separate causes.” The authors say the opposite: the pillars are highly intertwined.
- “AFAR’s economic claims are findings.” AFAR is an advocacy organisation; its statements on societal benefit are its own position.
FAQ
What is geroscience in simple terms?
The study of the biology of aging and how it drives chronic disease, with the aim of intervening in aging processes shared by many diseases.
Who proposed the seven pillars?
A group of researchers including Brian Kennedy, Shelley Berger, Anne Brunet and Judith Campisi, in Cell 159(4):709-713, 2014.
How is geroscience different from geriatrics?
Geroscience is a research field on aging mechanisms; geriatrics is clinical care of older adults. See the geriatrics vs gerontology comparison.
Sources
- Kennedy BK, Berger SL, Brunet A, et al. Aging: a common driver of chronic diseases and a target for novel interventions. Cell. 2014;159(4):709-713. doi:10.1016/j.cell.2014.10.039. PMC4852871. Read 2026-11-08.
- Leng SX, Liu B, Kennedy BK. Geroscience special-issue introduction. Aging Medicine. 2019;2(3):126-129. PMC6880738.
- American Federation for Aging Research. What is geroscience? Read 2026-11-08.
